Beth Smith - Jan 2, 2025 Form 3 Insider Report for MACROGENICS INC (MGNX)

Role
VP, Controller & Treasurer
Signature
Beth Smith
Stock symbol
MGNX
Transactions as of
Jan 2, 2025
Transactions value $
$0
Form type
3
Date filed
1/13/2025, 04:39 PM
Next filing
Feb 11, 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding MGNX Common Stock 7.89K Jan 2, 2025 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding MGNX Employee Stock Option (right to buy) Jan 2, 2025 Common Stock 3K $31.43 Direct F1
holding MGNX Employee Stock Option (right to buy) Jan 2, 2025 Common Stock 2.1K $20.53 Direct F2
holding MGNX Employee Stock Option (right to buy) Jan 2, 2025 Common Stock 4K $28.94 Direct F3
holding MGNX Employee Stock Option (right to buy) Jan 2, 2025 Common Stock 19.9K $21.88 Direct F4
holding MGNX Employee Stock Option (right to buy) Jan 2, 2025 Common Stock 4.5K $11.50 Direct F5
holding MGNX Employee Stock Option (right to buy) Jan 2, 2025 Common Stock 5K $19.18 Direct F6
holding MGNX Employee Stock Option (right to buy) Jan 2, 2025 Common Stock 6K $10.15 Direct F7
holding MGNX Employee Stock Option (right to buy) Jan 2, 2025 Common Stock 8K $2.44 Direct F8
holding MGNX Employee Stock Option (right to buy) Jan 2, 2025 Common Stock 15K $4.82 Direct F9
holding MGNX Restricted Stock Unit Jan 2, 2025 Common Stock 2.19K $0.00 Direct F10, F11
holding MGNX Employee Stock Option (right to buy) Jan 2, 2025 Common Stock 12.3K $18.30 Direct F12
holding MGNX Restricted Stock Unit Jan 2, 2025 Common Stock 4.75K $0.00 Direct F11, F13
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option was granted on 12/18/2015 and 12.5% of the shares underlying the grant become exercisable 6 months after the date of grant and an additional 6.25% of the shares underlying the grant become exercisable on the first day of each three-month period thereafter.
F2 This option was granted on 2/15/2017 and 12.5% of the shares underlying the grant become exercisable 6 months after the date of grant and an additional 6.25% of the shares underlying the grant become exercisable on the first day of each three-month period thereafter.
F3 This option was granted on 3/2/2018 and 12.5% of the shares underlying the grant become exercisable 6 months after the date of grant and an additional 6.25% of the shares underlying the grant become exercisable on the first day of each three-month period thereafter.
F4 This option was granted on 2/21/2019 and 12.5% of the shares underlying the grant become exercisable 6 months after the date of grant and an additional 6.25% of the shares underlying the grant become exercisable on the first day of each three-month period thereafter.
F5 This option was granted on 2/20/2020 and 12.5% of the shares underlying the grant become exercisable 6 months after the date of grant and an additional 6.25% of the shares underlying the grant become exercisable on the first day of each three-month period thereafter.
F6 This option was granted on 2/22/2021 and 12.5% of the shares underlying the grant become exercisable 6 months after the date of grant and an additional 6.25% of the shares underlying the grant become exercisable on the first day of each three-month period thereafter.
F7 This option was granted on 2/22/2022 and 12.5% of the shares underlying the grant become exercisable 6 months after the date of grant and an additional 6.25% of the shares underlying the grant become exercisable on the first day of each three-month period thereafter.
F8 This option was granted on 6/13/2022 and 12.5% of the shares underlying the grant become exercisable 6 months after the date of grant and an additional 6.25% of the shares underlying the grant become exercisable on the first day of each three-month period thereafter.
F9 This option was granted on 2/15/2023 and 12.5% of the shares underlying the grant become exercisable 6 months after the date of grant and an additional 6.25% of the shares underlying the grant become exercisable on the first day of each three-month period thereafter.
F10 The restricted stock units (RSUs) were granted on 2/15/2023 and vested as to 50% of the total shares one year after the date of grant and will vest 50% two years after the date of grant.
F11 Each restricted stock unit (RSU) represents a contingent right to receive one share of the Issuer's common stock.
F12 This option was granted on 2/8/2024 and 12.5% of the shares underlying the grant become exercisable 6 months after the date of grant and an additional 6.25% of the shares underlying the grant become exercisable on the first day of each three-month period thereafter.
F13 The restricted stock units (RSUs) were granted on 2/8/2024 and will vest as to 33% of the total shares one year after the date of grant and 33% each year thereafter.